← Alle mensen

AR

Anita Rimanti

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the S...

JAMA oncology · 1 april 2025

Negen weken versus één jaar trastuzumab bij HER2-positief mammacarcinoom: meta-analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 november 2023

5-FU en dosisdichte adjuvante chemotherapie bij mammacarcinoom: GIM2 langetermijn

The Lancet. Oncology · 2022-12

PIK3CA-mutatie en trastuzumab-duur bij HER2-positief mammacarcinoom: ShortHER analyse

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 november 2020